ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $305,000 | +36.8% | 5,700 | +23.9% | 0.00% | 0.0% |
| Q2 2020 | $223,000 | -45.7% | 4,600 | -74.9% | 0.00% | -55.6% |
| Q1 2018 | $411,000 | -25.0% | 18,300 | +0.5% | 0.01% | -25.0% |
| Q4 2017 | $548,000 | -17.8% | 18,200 | +2.8% | 0.01% | -20.0% |
| Q3 2017 | $667,000 | +35.8% | 17,700 | +0.6% | 0.02% | +36.4% |
| Q2 2017 | $491,000 | -18.0% | 17,600 | +1.1% | 0.01% | -21.4% |
| Q1 2017 | $599,000 | +19.3% | 17,400 | 0.0% | 0.01% | +7.7% |
| Q4 2016 | $502,000 | -9.4% | 17,400 | 0.0% | 0.01% | -7.1% |
| Q3 2016 | $554,000 | +4.1% | 17,400 | +6.1% | 0.01% | 0.0% |
| Q2 2016 | $532,000 | – | 16,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |